Thomas Weilby Knudsen
General Partner @ Northcap
Copenhagen, Denmark
Thomas Weilby Knudsen is a funding round investor at Northcap in Copenhagen focused on Software and SaaS. Thomas Weilby Knudsen - General Partner @ Northcap
- Total investments:
- 10
- Last investment:
- Lead investor:
- 10%
Last updated:
For AI agents: llms.txt
Industries Thomas Weilby Knudsen invests in
Stages Thomas Weilby Knudsen invests in
Countries Thomas Weilby Knudsen invests in
Investment Focus
Industry
- Software 4 (40%)
- SaaS 2 (20%)
- Enterprise Software 2 (20%)
- Information Technology 2 (20%)
- SMS 1 (10%)
Stage
- Funding Round 3 (30%)
- Series B 2 (20%)
- Series A 1 (10%)
- Series C 1 (10%)
- Series D 1 (10%)
Country
- Denmark 4 (40%)
- United States 2 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Visiopharm
|
Visiopharm image analysis and stereology software has become the preferred Quantitative Digital Pathology solution for leading biopharmaceutical companies, contract research organizations (CRO), academic medical centers, research institutes, and hospitals all over the world. Recently, Visiopharm has expanded to include ONCOtopix™ Dx a robustsolution for cancer diagnostics with CE-IVD algorithms for the breast panel, integrated LIS driven workflow, and Virtual Double Staining. Their software is featured in over 800 scientific publications, and is compatible with leading slide scanner manufacturers, data management software, and a wide variety of microscopes and cameras.Visiopharm, a privately owned company, was founded in 2001 by the Managing Director, and Chief Executive Officer, Michael Grunkin and the Chief Technical officer, Johan Doré Hansen, who both have a strong scientific and practical background in image analysis.Their company has grown into an international business with over 500 licenses in more than 30 countries. Their growing network of authorized distributors and partners support the growth of Visiopharm solutions on several continents including North America, Europe and Asia. Their headquarters is located in the Medicon Valley of Denmark, with a branch office in the Netherlands, and a North America office in Broomfield, Colorado. | Sep 01, 2020 | |
|
Visiopharm
|
Visiopharm image analysis and stereology software has become the preferred Quantitative Digital Pathology solution for leading biopharmaceutical companies, contract research organizations (CRO), academic medical centers, research institutes, and hospitals all over the world. Recently, Visiopharm has expanded to include ONCOtopix™ Dx a robustsolution for cancer diagnostics with CE-IVD algorithms for the breast panel, integrated LIS driven workflow, and Virtual Double Staining. Their software is featured in over 800 scientific publications, and is compatible with leading slide scanner manufacturers, data management software, and a wide variety of microscopes and cameras.Visiopharm, a privately owned company, was founded in 2001 by the Managing Director, and Chief Executive Officer, Michael Grunkin and the Chief Technical officer, Johan Doré Hansen, who both have a strong scientific and practical background in image analysis.Their company has grown into an international business with over 500 licenses in more than 30 countries. Their growing network of authorized distributors and partners support the growth of Visiopharm solutions on several continents including North America, Europe and Asia. Their headquarters is located in the Medicon Valley of Denmark, with a branch office in the Netherlands, and a North America office in Broomfield, Colorado. | $13.5M / Aug 23, 2018 | |
Falcon.io
|
Falcon.io offers a unified SaaS platform for social media listening, engaging, publishing and managing customer data. Falcon clients can explore the full potential of digital marketing by managing multiple customer touch points from one platform.The diverse and global client portfolio includes Carlsberg, Tiger, Columbia University, IWC Watches,Momondo, Coca-Cola and much more. | $7M / Series C / Feb 15, 2017 | |
|
Falcon.io
|
Falcon.io offers a unified SaaS platform for social media listening, engaging, publishing and managing customer data. Falcon clients can explore the full potential of digital marketing by managing multiple customer touch points from one platform.The diverse and global client portfolio includes Carlsberg, Tiger, Columbia University, IWC Watches,Momondo, Coca-Cola and much more. | $20M / Series B / Mar 24, 2015 | |
|
Falcon.io
|
Falcon.io offers a unified SaaS platform for social media listening, engaging, publishing and managing customer data. Falcon clients can explore the full potential of digital marketing by managing multiple customer touch points from one platform.The diverse and global client portfolio includes Carlsberg, Tiger, Columbia University, IWC Watches,Momondo, Coca-Cola and much more. | $6.4M / Series A / Aug 16, 2013 | |
IntelePeer
|
We enable companies to communicate better – driving more revenue, improving their customer experience, and making better business decisions – leveraging omni-channel Automation & Self-Service, AI, and Analytics, all delivered through a single easy-to-use cloud platform that works seamlessly with your existing business solutions. | $15M / Series D / Jun 10, 2013 | |
Insurance Business Applications
|
Insurance Business Applications is creating a new category and a new generation of insurance software solutions. Their multi-channel sales front-end helps agents and insurance companies swiftly and efficiently adapt to the dynamics of their distribution model. IBApps helps some of the largest insurance companies in the World bring new products tomarket faster and more efficiently. | Feb 08, 2013 | |
Octoshape
|
Octoshape ApS provides live and on-demand streaming audio and video technology. The company offers live streaming solutions for Webcasts from live events, including sport matches, musical events, or award shows; and hosted radio streaming solutions. It also provides hosted television streaming solutions; and OctoSource signal distribution solution,which allows broadcasters to get signals through Internet connection, enabling broadcasts from a range of events in sports, music, and entertainment. The company was founded in 2003 and is based in Copenhagen, Denmark. | Apr 01, 2009 | |
|
Visiopharm
|
Visiopharm image analysis and stereology software has become the preferred Quantitative Digital Pathology solution for leading biopharmaceutical companies, contract research organizations (CRO), academic medical centers, research institutes, and hospitals all over the world. Recently, Visiopharm has expanded to include ONCOtopix™ Dx a robustsolution for cancer diagnostics with CE-IVD algorithms for the breast panel, integrated LIS driven workflow, and Virtual Double Staining. Their software is featured in over 800 scientific publications, and is compatible with leading slide scanner manufacturers, data management software, and a wide variety of microscopes and cameras.Visiopharm, a privately owned company, was founded in 2001 by the Managing Director, and Chief Executive Officer, Michael Grunkin and the Chief Technical officer, Johan Doré Hansen, who both have a strong scientific and practical background in image analysis.Their company has grown into an international business with over 500 licenses in more than 30 countries. Their growing network of authorized distributors and partners support the growth of Visiopharm solutions on several continents including North America, Europe and Asia. Their headquarters is located in the Medicon Valley of Denmark, with a branch office in the Netherlands, and a North America office in Broomfield, Colorado. | Oct 05, 2007 | |
Nangate
|
Standard-cell libraries were introduced more than 40 years ago to help IC designers keep up with the increasing complexity of IC design. But the convenience offered by predefined digital CMOS standard cells has come at the price of overall chip-level efficiency. Standard-cell-based ICs are rarely optimized for their intended application, so ICs arenot as small, fast or power-efficient as they could be.Nangate cell library creation and optimization tools provide the answer to this dilemma. Nangate tools enable custom tailoring of digital cell libraries to meet specific design targets. Libraries can be optimized for design goals such as power consumption, die area, operating frequency or required yield – as opposed to being designed for a broad range of standard requirements. The result: improvements in IC performance can be achieved at much lower cost and with considerably less effort than using full-custom design methods. | $15M / Series B / Jan 01, 2007 |
Co-Investors
Target Partners
3 deals together
Prime Ventures
2 deals together
ATP
1 deal together
BankInvest
1 deal together
Cipio Partners
1 deal together
About Northcap
Northcap is a venture capital company that provides funds and support for ICT companies based on the technologies of cloud computing, communications, mobile and mobility, online services, and e-commerce. It funds companies in three stages of development such as seed stage: invests in Danish companies from the first revenue onwards; early stage:invests i companies with a proven business model and a revenue of €1-2 million or more in the Northern part of Europe; and growth stage: invests in well-established Northern European companies with a revenue of €10-25 million.Northcap covers several essential areas of technology businesses development, including strategy, internationalization, sales processes, recruitment of employees, and organization.Northcap is based in Copenhagen, Denmark.
Northcap Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Frank Ewald
Member, Advisory Board
|
|||
Kenneth Dambo
Early Stage Investor
|
|||
Kim Wiencken
General Partner
|
|||
Lars Bruhn
Chairman & Founder
|
|||
|
Thomas Weilby Knudsen
General Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Thomas Weilby Knudsen invest in?
Thomas Weilby Knudsen invests primarily in Software, SaaS and Enterprise Software startups, most often at Funding Round and Series B stage. Most of the 10 investments tracked by Shizune back companies in Denmark. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Thomas Weilby Knudsen last invest?
The most recent investment recorded for Thomas Weilby Knudsen closed in Sep 2020. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
